What should a researcher verify before tesamorelin acetaat online kopen from Australia?
A researcher evaluating tesamorelin acetaat online kopen is comparing research-grade lyophilised solids, not a pharmacy finished product. The discriminating artefacts are the CoA, the HPLC chromatogram, the mass spectrum and the lot identifier on the vial. Those files should be lot-linked before purchase, or at least bound to the same batch that will leave Australian stock under tracked dispatch.
Start with nomenclature. Dutch acetaat corresponds to English tesamorelin acetate. The peptide portion is the trans-3-hexenoyl analogue of growth hormone-releasing factor. Confirm that the CoA states that analogue—sequence, modification note or molecular formula—and that the counterion field says acetate rather than trifluoroacetate or an unspecified salt. A catalogue name that does not match the CoA salt field is a documentation failure.
Lot concordance is next. The vial label, CoA header, chromatogram footer and spectrum header should share one lot code. A generic typical CoA that is not lot-linked cannot support incoming-goods identity checks. Local Australian stock is useful because the paperwork reviewed is the paperwork that ships, without silent batch substitution.
Discriminating analytical fields include HPLC area-percent purity at a stated wavelength, a related-substances table with relative retention times, intact mass with theoretical and observed values, acetate content, Karl Fischer water, and net peptide content where measured. Missing instrument conditions make a purity number non-transferable. The intended-use statement should read research use only. Copy that implies human use, compounding or substitution for a registered product is outside research-reagent scope and should be treated as a compliance mismatch rather than a convenience.
How is tesamorelin chemically defined as a trans-3-hexenoyl GHRH analogue?
Published descriptions treat tesamorelin as a human growth hormone-releasing factor analogue: a synthetic 44-amino-acid peptide whose N-terminus carries a trans-3-hexenoyl group. Expert reviews describe that analogue identity in the pharmacological literature, and concise drug-discovery notes use the same chemical classification. A research CoA should reproduce that identity as a sequence string, a modification note, or a molecular formula from which theoretical mass is calculated.
The hexenoyl moiety is the main discriminator versus unmodified GHRH(1–44) and versus truncated fragments. In mass spectrometry it contributes a defined mass increment relative to the unmodified chain. In reversed-phase HPLC it increases N-terminal hydrophobicity and typically shifts retention relative to des-hexenoyl related substances. A CoA that prints tesamorelin without the N-terminal modification, or that reports a mass matching the unmodified chain, has not established the analogue the name claims. Orthogonal confirmation—intact mass plus a fragment ion or mapping peptide that localises the hexenoyl group—is stronger than a single ultraviolet peak.
Salt form is a second identity layer. Acetate can be quantified by ion chromatography or a dedicated HPLC assay and must be distinguished from residual trifluoroacetate remaining from preparative ion-pairing. A lot labelled acetate but showing high trifluoroacetate and negligible acetate has a salt-form discrepancy. Net peptide content then states how much of the weighed solid is peptide rather than counterion, water and residual solvents.
Because tesamorelin is a long synthetic chain, deletion sequences, incomplete couplings and truncated C-terminal amides are chemically plausible. Retention-time matching alone cannot separate co-eluting truncations of similar hydrophobicity. The literature analogue description therefore operates as a specification: the laboratory should be able to read every identity field against the hexenoyl 44-mer acetate structure.
Which intact-mass ppm window and charge-state envelope belong on the CoA?
Intact-mass identity for a 44-residue analogue is almost always electrospray ionisation on a multiply charged envelope. Tesamorelin in positive-ion ESI typically presents a charge-state series whose exact charges depend on solvent and instrument. The CoA should state which charge states were deconvoluted, the deconvoluted mass, the theoretical mass from the declared sequence plus the trans-3-hexenoyl modification and any claimed C-terminal amide, and the mass error in daltons or parts per million.
Laboratories declare an identity window rather than a single magic number. For quadrupole or time-of-flight peptide quality control, windows from a few hundred ppm down to low-ppm agreement are commonly documented; the purchaser needs the window to be pre-stated and the observed value to fall inside it. Average mass and monoisotopic mass must not be mixed. Comparing a theoretical average mass with a monoisotopic deconvolution creates a systematic offset and can falsely pass or fail a lot. The report should name the mass type used.
Related-substance masses belong with identity. Loss of the hexenoyl group, oxidation where a sulphur-containing residue is present, deamidation (approximately +0.98 Da when unresolved at the intact level) and single-residue deletions produce predictable shifts. If the main envelope matches tesamorelin but a second envelope matches des-hexenoyl material at non-trivial intensity, the HPLC table should show a corresponding peak. Discordance between mass spectrometry and ultraviolet data is a method or integration problem that needs explanation on the report.
Instrument metadata—ionisation mode, analyser, calibration reference, acquisition range and deconvolution software—make the printed mass-found versus mass-calculated line auditable. Peptide mapping or tandem mass-spectrometry ions that include the N-terminal hexenoyl-bearing fragment reduce the risk that an isobaric impurity is counted as parent. Incoming inspection should archive the supplier spectrum and, where the laboratory has ESI capability, repeat intact mass on the same lot within the same window.
How do acetate assay and Karl Fischer water complete tesamorelin mass balance?
Labelled vial mass is not peptide content. Lyophilised tesamorelin acetate contains peptide, acetate, residual water, and often residual process solvents or residual trifluoroacetate. Treating every milligram on the label as peptide will bias gravimetric standards. Mass-balance fields on the CoA exist to prevent that error.
Acetate assay, typically ion chromatography with conductivity detection or a validated HPLC method, reports acetate as a mass fraction or as moles of acetate per mole of peptide. For a lot sold as the acetate salt, acetate should be consistent with ion-pairing of basic sites under the isolation conditions, not a trace residual. Trifluoroacetate should be reported when preparative TFA ion-pairing was used. Lots counterion-exchanged from TFA to acetate should show high acetate and low TFA; lots that were not exchanged should not be labelled acetaat.
Karl Fischer residual water is usually coulometric, with sample handling that limits atmospheric uptake. Water is not an HPLC peptide impurity, yet it contributes to weighed mass. A CoA without water, or with a non-specific loss-on-drying figure only, leaves a hole in the balance. Elevated water can also indicate cake handling or container-closure issues relevant to laboratory storage records.
Net peptide content closes the arithmetic. NPC is commonly obtained by nitrogen analysis, amino-acid analysis, or quantitative NMR after counterion and water correction. The purchaser should be able to write: labelled solid approximates peptide plus acetate plus other counterions plus water plus residual solvents, within analytical uncertainty. HPLC area-percent purity then applies to the peptide fraction, not the entire powder. Two lots with identical HPLC purity can differ in peptide per milligram if acetate and water differ. When comparing Australian catalogue listings, normalise to NPC and to the identity fields rather than to the raw milligram label. That is the analytical meaning of acetaat in this search: a declared salt form whose counterion and water have been measured.
Which HPLC fields and Australian batch-pack documents must match the vial lot?
Reversed-phase HPLC is the purity workhorse for tesamorelin research lots. Long, moderately hydrophobic analogues are usually run on a wide-pore C18 (or C4) column with an acetonitrile gradient, an ion-pair reagent, and ultraviolet detection at 210–220 nm. The CoA should print column identity and dimensions, mobile-phase composition, gradient table, flow, temperature, load volume and detection wavelength. A purity percentage without those conditions is not transferable between laboratories.
Area-percent purity is not assay. After excluding solvent fronts and system peaks, area normalisation estimates chromatographic purity of detected peptide-related peaks; it does not measure milligrams of tesamorelin per milligram of powder. Look for a reporting threshold and a related-substances table with relative retention time, area percent and, where known, a mass assignment. Unidentified peaks above the threshold should remain as UNK rows. System suitability—tailing, plate count or peak width, resolution to a neighbour, replicate-area and retention-time repeatability—must pass or the purity number is invalid. Chromatogram headers should repeat the lot code so a PDF cannot be reused across batches.
Inspect whether the gradient resolves early hydrophilic truncations and des-hexenoyl species from the main peak and whether late hydrophobic deletions are integrated to the end of the run. Diode-array peak-purity indices are weak for peptides with similar ultraviolet spectra; paired LC-MS is the orthogonal check.
Australian batch packs bind those chromatograms to physical vials. A complete pack contains the CoA (identity, HPLC purity, related substances, intact mass, acetate, water, NPC if measured), the chromatogram PDF, the deconvoluted spectrum, and a research-use-only statement. Local stock and tracked dispatch mean the lot on the CoA is the lot picked, with a consignment identifier filed beside the report. Compare vendors on documentation density: hexenoyl declared, masses printed, acetate and water quantified, HPLC conditions and peak table present, lot codes concordant. ClaraScience supplies research peptides from Australian stock with batch documentation; the purchaser remains responsible for research-only use and for checking that the CoA matches the vials received.
Order Tesamorelin with documentation
If this guide helped you evaluate Tesamorelin for laboratory work, the next step is documented supply: research-grade stock from Australian warehouses, Express tracked shipping, and batch documentation with every order.
Open the Tesamorelin card on the ClaraScience shop for current stock and add-to-cart, or request wholesale access when you need bulk restocks and tier pricing.
Frequently asked questions
Does tesamorelin acetaat online kopen refer to a research reagent or a pharmacy product?
In a research-catalogue context it refers to lyophilised tesamorelin acetate intended for laboratory work, not a registered pharmacy medicine. Evaluate the CoA, lot concordance, intact mass, acetate assay, Karl Fischer water and HPLC purity. Intended-use text should state research use only.
What intact-mass information should a tesamorelin acetate CoA include?
The report should list theoretical mass from the declared hexenoyl 44-mer sequence, observed deconvoluted mass, mass error, mass type (average or monoisotopic), charge states used, and instrument metadata. The observed value should fall inside a pre-declared identity window. Des-hexenoyl envelopes should match the HPLC related-substances table.
Why measure acetate and Karl Fischer water if HPLC purity is already reported?
HPLC area percent describes chromatographic purity of peptide-related peaks, not milligrams of peptide per milligram of powder. Acetate and water are major contributors to labelled solid mass. Net peptide content plus those assays let the laboratory convert vial mass into peptide mass for gravimetric standards.
How do Australian local stock and tracked dispatch help lot traceability?
Local stock means the CoA you review can match the vials picked, without undocumented batch substitution. Tracked dispatch supplies a consignment identifier and scan history to file beside the CoA. Neither replaces identity testing; both bind paperwork to the physical lot received.
Which HPLC related-substances details are expected for tesamorelin research lots?
Expect method conditions, a reporting threshold, and a peak table with relative retention times and area percents, including unidentified peaks above the threshold. Early truncations and des-hexenoyl species, and late hydrophobic deletions, should be integrated. System suitability must pass for the purity figure to be valid.
What salt-form discrepancy should stop a tesamorelin acetaat purchase?
If the catalogue and vial say acetate but the CoA shows high residual trifluoroacetate and little acetate, the salt form is not the labelled acetaat. Request the acetate assay, TFA residual and net peptide content before accepting the lot for research use.
References
- PMID:19243281 — Tesamorelin, a human growth hormone releasing factor analogue — Expert Opin Investig Drugs — 2009
- PMID:21283099 — Tesamorelin — Nat Rev Drug Discov — 2011
- PMID:22298602 — Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy — Ann Pharmacother — 2012
- PMID:21668043 — Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy — Drugs — 2011
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
